Navigation Links
Eppendorf Reference Series 2000 adjustable-volume Pipette, 500-2,500 l

ProductsEppendorf Reference Series 2000 adjustable-volume Pipette, 500-2,500 l
Company Eppendorf North America
Item Eppendorf Reference Series 2000 adjustable-volume Pipette, 500-2,500 l
Features 
Description The Eppendorf Reference Series 2000 Pipette is a synonym for pipetting accuracy, a smooth stroke, a compact and robust design, and superior operating comfort. Its single, multifunctional button is used to operate the measuring stroke and blow-out as well as eject the tip. Product features:Eppendorf "pipette/tip" system ensures utmost accuracy and precision. Ejection sleeve can be removed to fit into smaller vessels. Smooth-running piston is corrosion-free and chemically resistant . UV-resistant and completely autoclavable without any impairment of accuracy or precision.
Info Eppendorf North America
Customer Service: (800) 645-3050
Web site: http://www.eppendorfna.com/home/

Related medicine products :

1. Eppendorf Thermomixer
2. Eppendorf Thermomixer R
3. Eppendorf ThermoStat Plus, without block
4. Eppendorf Refrigerated Multipurpose Centrifuge Model 5804R
5. Eppendorf Refrigerated Multipurpose Centrifuge Model 5810R
6. Eppendorf Heat Sealing Film
7. Eppendorf heat sealing film
8. Eppendorf PCR film, self adhesive
9. Eppendorf Heat Sealing Foil
10. Eppendorf PCR foil, self adhesive
11. Eppendorf Sealing Mat 96
Simplex™ P with Tobramycin is the original Simplex™ P Bone Cement formula, with the addition of 1g of tobramycin. By maintaining the original formula, surgeons can expect the superior per
For over 35 years, Palacos Bone Cement has clinically proven itself as the gold standard in cemented arthroplasty. And since the introduction of,the Optivac system in 1986, the Palacos/Optivac com
Occu-Flo Plugs Offer: , Easy Insertion , A polished, smooth, transparent finish which creates immediate patient comfort and adaptation , High tolerance by patients , No discomfort should removal be
Inserted into the punctal opening to block tear drainage through the canaliculus, collagen plugs provide temporary relief of dry eye symptoms:, Manufactured from precisely measured premium collagen,
Medicine Products:
(Date:12/3/2008)...-USNewswire/ -- In recognition of the value the Am...rship, ASH is proud to honor George Buchanan, M.D...., which highlight the important role mentors play ...matologists early in their careers. , , Eac... laboratory science and the other from patient-ori...
(Date:12/3/2008)...-USNewswire/ -- The American Society of Hematology...f blood specialists, will recognize the Speaker of...Director of the National Heart, Lung, and Blood In...dical research. The Public Service awards will be ...nnual Meeting in San Francisco, CA. , , The...
(Date:12/3/2008)... A new study led by researchers at Albert Einstei...arified how two major variants of HIV differ in th...e finding, published in Journal of Neuroscience ,...ent HIV-associated dementia, an incurable and incr...Even with anti-retroviral drug therapies, up to on...
(Date:12/3/2008)...swire/ -- The American College of Surgeons (ACS) t...r its committee report on resident duty hours that...ittee on Optimizing Graduate Medical Trainee (Resi...Safety. , , ACS agrees with the IOM in it...ed 80-hour work week (averaged over four weeks) ar...
Breaking Medicine News(10 mins):Health News:Inspirational Hematologists Honored With Mentor Awards From the American Society of Hematology 2Health News:ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research 2Health News:ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research 3Health News:Study sheds light on causes of HIV dementia 2Health News:Study sheds light on causes of HIV dementia 3Health News:American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours 2
...deadliest bacterial pathogen may soon be fighting ...rsity in New York say they have successfully stopp...from the immune system.// It typically hides out i... macrophage. The researchers say they have identif...
...w study shows kidney patients have far more to be ...can Heart Association-sponsored study shows //peop...risk group for heart disease. Doctors say the most... applies to people who are in the very early stage...
...ious studies have shown inhaled corticosteroids ca...r, researchers now say long-term use of ICS therap...MD. // Corticosteroids are commonly used to treat ...tructive pulmonary disorder. Researchers say these...
...ght stigma is powerful, pervasive and destructive,...e English study, psychologists tested 144 female s...d a dapper, thin young man standing next to a svel...e same photo altered to show the guy arm-in-arm wi...
Other Medicine News:
(Date:12/3/2008)... 3 Isogen, a contract development ...g, announced it has retained a,strategic financia... global,biopharma demand for Isogen,s services. ,...ul first round series of capital,investment and t...1 2009 to,deliver on the previously unmet process...
(Date:12/3/2008)... Vical Incorporated,(Nas...g letter of intent with EIP,Eczacibasi Ilac Pazar...pany,s,Allovectin-7(R) immunotherapeutic product ...orthern Cyprus. EIP has agreed to obtain the neces...o pay Vical upfront and milestone payments,plus a...
(Date:12/2/2008)...Dec. 2 Biopure Corporati.... Naval Medical Research Center,(NMRC) has submit...vised,investigational new drug (IND) application ...en therapeutic Hemopure(R) [hemoglobin glutamer - ...eatment of trauma patients. The study is,entitled...
(Date:12/2/2008)... 2 Horizon Therapeutics, Inc., a,...nounced that two pivotal,Phase 3 trials evaluatin...501,met all primary endpoints. HZT-501, a novel,...ining ibuprofen and famotidine, demonstrated a,st... of non-steroidal,anti-inflammatory drug (NSAID)-...
Breaking Medicine Technology:Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Who will recover spontaneously from hepatitis C virus infection 175 1Who will recover spontaneously from hepatitis C virus infection 175 2SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th 238 1Prolexys Pharmaceuticals Initiates Phase 1 Study 157 1Prolexys Pharmaceuticals Initiates Phase 1 Study 157 2Amsterdam Molecular Therapeutics Reports Half Year Results 2007 233 1Amsterdam Molecular Therapeutics Reports Half Year Results 2007 233 2Amsterdam Molecular Therapeutics Reports Half Year Results 2007 233 3Amsterdam Molecular Therapeutics Reports Half Year Results 2007 233 4Amsterdam Molecular Therapeutics Reports Half Year Results 2007 233 5Amsterdam Molecular Therapeutics Reports Half Year Results 2007 233 6Amsterdam Molecular Therapeutics Reports Half Year Results 2007 233 7
...e--(BUSINESS WIRE)--Jun 28, 2007 - ZIOPHARM Oncolo...ntation of two,posters at the XIth Annual Internat...rom June 25-28th, 2007. The meeting highlights,imp...of multiple,myeloma. ZIOPHARM is presenting darina...at further elucidates its unique,mechanism of acti...
...sented at the 11th International Myeloma Workshop ...29, 2007,/PRNewswire/ -- The International Myeloma...ding education, advocacy and support,for myeloma p...oday,said that updated statistics reported at the ...nstrate improved survival for a wide,range of myel...
Other Medicine Technology:ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 2ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 3ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 4The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 2The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 3The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 4